Actively Recruiting
Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
Led by Xi Shan Wang · Updated on 2024-06-03
3060
Participants Needed
22
Research Sites
504 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the efficacy and safety of Huaier granules for Prevention of Recurrence and Metastasis of colorectal cancer patients following radical surgery
CONDITIONS
Official Title
Huaier Granules for Prevention of Recurrence and Metastasis of Colorectal Cancer Patients Following Radical Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males or females ages 18-75 years
- First time therapy patients who received radical surgery within two months
- Postoperative histopathology confirming stage IIB, IIC, or III colorectal cancer (TNM classification)
- ECOG score of 0-2
- No history of malignant tumors
- Volunteered for the study, signed informed consent, and agree to data collection
You will not qualify if you...
- Heart diseases, cerebrovascular disease, lung disease, severe hypertension, or poorly controlled diabetes
- Confirmed infections after surgery
- Post-surgery complications or effects from radical colorectal cancer surgery
- Infection with syphilis or other blood-borne infectious diseases
- Pregnancy, lactation, or women of childbearing potential not using contraception
- Use of Traditional Chinese Medicines similar to Huaier granule (e.g., compound Banmao capsule, Huachansu capsule, Kangai Injection, Pingxiao tablets)
- Mental illness or conditions deemed unsuitable by study investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 22 locations
1
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Actively Recruiting
2
The First Clinical Hospital affiliated to Harbin Medical University
Harbin, Heilongjiang, China
Actively Recruiting
3
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Actively Recruiting
4
Hubei Cancer Hospita
Wuhan, Hubei, China
Actively Recruiting
5
Union Hospital Tongji College Huazhong University of Science and Technology
Wuhan, Hubei, China
Actively Recruiting
6
Hunan Provincial People's Hospital
Changsha, Hunan, China
Actively Recruiting
7
Xiangya Hospital Central South University
Changsha, Hunan, China
Actively Recruiting
8
Changzhou No.2 People's Hospital
Changzhou, Jiangsu, China
Actively Recruiting
9
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Actively Recruiting
10
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, China
Actively Recruiting
11
Anshan Cancer Hospital
Anshan, Liaoning, China
Actively Recruiting
12
Ansteel Group General Hospital
Anshan, Liaoning, China
Actively Recruiting
13
The First Affiliated Hospital of Jinzhou Medical University
Jinzhou, Liaoning, China
Actively Recruiting
14
Shandong Provincial Hospital
Jinan, Shandong, China
Actively Recruiting
15
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China
Actively Recruiting
16
Yantai Yuhuangding Hospital
Yantai, Shandong, China
Actively Recruiting
17
Zaozhuang Municipal Hospital
Zaozhuang, Shandong, China
Actively Recruiting
18
First Affiliated Hospital of Xi'an Jiaotong University
Xi’an, Shanxi, China
Actively Recruiting
19
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China
Actively Recruiting
20
First Affiliated Hospital of Xinjiang Medical University
Ürümqi, Xinjiang, China
Actively Recruiting
21
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
Actively Recruiting
22
Fudan University Shanghai Cancer Center
Shanghai, China
Actively Recruiting
Research Team
X
Xishan Wang, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here